Literature DB >> 26438010

The intraindividual impact of ADHD on the transition of adulthood to old age.

Florence Philipp-Wiegmann1, Petra Retz-Junginger2, Wolfgang Retz3, Michael Rösler2.   

Abstract

The aim of the study was to explore whether the individual burden of ADHD is the same in the elderly as in younger ages even though the symptomatological impact of ADHD seems to remain stable over the lifespan. To assess ADHD symptoms and ADHD-associated problems in daily life, standardised questionnaires were conducted. To assess the subjectively experienced course of disease over the lifespan, all participants were interviewed regarding symptoms of ADHD in childhood as well as before and after the fiftieth year of life. In the sample of 296 respondents with a mean age of 69.55 years, 11 fulfilled the criteria of adult ADHD. Retrospectively, the ADHD subjects reported negative impacts due to ADHD-associated behaviour over the life span. These impairments remained stable over time with 18 % of subjects reporting impairments in family life, 46 % in social relationships, 18 % in dealing with money, and 36 % in organisation of daily life in the presence. Thus, the ADHD subjects reported problems with stability over time caused by low self-confidence, being quick-tempered, and due to defiantness. Although this is pilot study, our results reflect the burden of ADHD not only in young and middle adulthood, but also in seniority. The findings indicate the lifelong impact of ADHD as the explored seniors with ADHD reported the negative impact of ADHD remaining stable over the lifespan.

Entities:  

Keywords:  ADHD; Adult; Attention-deficit/hyperactivity disorder; Old age

Mesh:

Year:  2015        PMID: 26438010     DOI: 10.1007/s00406-015-0644-7

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  28 in total

1.  ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Authors:  Laurel A Habel; William O Cooper; Colin M Sox; K Arnold Chan; Bruce H Fireman; Patrick G Arbogast; T Craig Cheetham; Virginia P Quinn; Sascha Dublin; Denise M Boudreau; Susan E Andrade; Pamala A Pawloski; Marsha A Raebel; David H Smith; Ninah Achacoso; Connie Uratsu; Alan S Go; Steve Sidney; Mai N Nguyen-Huynh; Wayne A Ray; Joe V Selby
Journal:  JAMA       Date:  2011-12-12       Impact factor: 56.272

2.  Cohort profile: the Longitudinal Aging Study Amsterdam.

Authors:  Martijn Huisman; Jan Poppelaars; Marleen van der Horst; Aartjan T F Beekman; Johannes Brug; Theo G van Tilburg; Dorly J H Deeg
Journal:  Int J Epidemiol       Date:  2011-01-06       Impact factor: 7.196

3.  Attention deficit hyperactivity disorder and personality characteristics in older adults in the general Dutch population.

Authors:  Marieke Michielsen; Hannie C Comijs; Evert J Semeijn; Aartjan T F Beekman; Dorly J H Deeg; J J Sandra Kooij
Journal:  Am J Geriatr Psychiatry       Date:  2014-02-25       Impact factor: 4.105

Review 4.  Systematic review of national and international guidelines on attention-deficit hyperactivity disorder.

Authors:  Miguel Seixas; Margaret Weiss; Ulrich Müller
Journal:  J Psychopharmacol       Date:  2011-09-24       Impact factor: 4.153

Review 5.  The unmet needs of all adults with ADHD are not the same: a focus on Europe.

Authors:  Ylva Ginsberg; Kathleen Marie Beusterien; Kaitlan Amos; Claude Jousselin; Philip Asherson
Journal:  Expert Rev Neurother       Date:  2014-06-04       Impact factor: 4.618

Review 6.  Attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Stephen V Faraone
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

7.  Relative lack of cognitive effects of methylphenidate in elderly male volunteers.

Authors:  Danielle C Turner; Trevor W Robbins; Luke Clark; Adam R Aron; Jonathan Dowson; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2003-05-07       Impact factor: 4.530

Review 8.  Nonstimulant treatment of adult attention-deficit/hyperactivity disorder.

Authors:  Thomas Spencer; Joseph Biederman; Timothy Wilens
Journal:  Psychiatr Clin North Am       Date:  2004-06

9.  An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder.

Authors:  R D Hunt; A F Arnsten; M D Asbell
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-01       Impact factor: 8.829

10.  Old people reporting childhood AD/HD symptoms: retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65-80.

Authors:  Taina Guldberg-Kjär; Boo Johansson
Journal:  Nord J Psychiatry       Date:  2009       Impact factor: 2.202

View more
  4 in total

1.  Neurobiological background of borderline personality disorder, PTSD and ADHD.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-06       Impact factor: 5.270

2.  Sex-specific relationships of the infant microbiome and early-childhood behavioral outcomes.

Authors:  Susan A Korrick; Juliette C Madan; Hannah E Laue; Margaret R Karagas; Modupe O Coker; David C Bellinger; Emily R Baker
Journal:  Pediatr Res       Date:  2021-11-04       Impact factor: 3.953

3.  Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder.

Authors:  Geon Ho Bahn; Young Sik Lee; Hanik K Yoo; Eui-Jung Kim; Subin Park; Doug Hyun Han; Minha Hong; Bongseog Kim; Soyoung Irene Lee; Soo Young Bhang; Seung Yup Lee; Jin Pyo Hong; Yoo-Sook Joung
Journal:  Soa Chongsonyon Chongsin Uihak       Date:  2020-01-01

4.  Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.

Authors:  Qi Chen; Catharina A Hartman; Jan Haavik; Jaanus Harro; Kari Klungsøyr; Tor-Arne Hegvik; Rob Wanders; Cæcilie Ottosen; Søren Dalsgaard; Stephen V Faraone; Henrik Larsson
Journal:  PLoS One       Date:  2018-09-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.